Previous 10 | Next 10 |
Matinas BioPharma Holdings (NYSEMKT: MTNB ) has priced its public offering of 32.26M common shares at $1.55 per share for expected gross proceeds of ~$50M. More news on: Matinas BioPharma Holdings, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Shares of Matinas BioPharma (NYSEMKT: MTNB) lost nearly 17% today after Amarin (NASDAQ: AMRN) reported preliminary full-year 2019 operating results and provided a business update. Both companies are developing drugs based on omega-3 fatty acids to treat cardiovascular disorders, although...
Gainers: Genetic Technologies (NASDAQ: GENE ) +120% . More news on: Genetic Technologies Limited, Cellect Biotechnology Ltd., Apache Corporation, Stocks on the move, Read more ...
CTI Industries (NASDAQ: CTIB ) -20% . More news on: CTI Industries Corporation, Inpixon, Pier 1 Imports, Inc., Stocks on the move, Read more ...
Matinas BioPharma Holdings, Inc.'s (NYSE: MTNB ) stock grew over 200 percent in the past 12 months and is currently trading close to its 52-week high of $2.49. However, there are a few things which may hamper the stock’s upward trajectory. The company is in nuanced competition with Am...
Matinas BioPharma 's (NYSEMKT: MTNB) shares slipped 13.4% on Monday. This came after Amarin Corp. (NASDAQ: AMRN) secured approval from the Food and Drug Administration to include a cardiovascular outcomes benefit on the prescription label for Amarin's purified omega-3 drug, Vascepa. Am...
These Penny Stocks On Robinhood Rallied Last Week; Can That Continue Monday? This coming week has a lot going for it already and it isn’t even Monday yet. For those who like penny stocks , that could be a very good thing. Late last week we saw the US and China seemingly reach a Phase 1...
Amneal Pharmaceuticals (NYSE: AMRX ) +32% as FDA OKs Amneal ANDA for EluRyng. More news on: Amneal Pharmaceuticals, Inc., LMP Automotive Holdings, Inc., Pintec Technology Holdings Limited, Stocks on the move, Read more ...
BEDMINSTER, N.J., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has entered into a feasibility evaluation with Genentech, a member of the Roche Group. This feasibility evaluation will involve the development of oral formula...
Synthorx (NASDAQ: THOR ) +169% on being acquired by Sanofi. More news on: Synthorx, Inc., XBiotech Inc., ArQule, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Matinas Biopharma Holdings Inc. Company Name:
MTNB Stock Symbol:
NYSE Market:
Matinas Biopharma Holdings Inc. Website:
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful...
BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces that MAT2203, its ora...
BEDMINSTER, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces new in vitro data ...